SCHEMBL8477332

SCHEMBL8477332

COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)N(CC(C)N(C)C)C1=O)cn2C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD1 Q15139 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CCNT1 O60563 1/20 0.51
PIM1 P11309 1/20 0.51
CDK9 P50750 1/20 0.51
PRKACA P17612 4/20 0.48
PRKACG P22612 4/20 0.48
PRKACB P22694 4/20 0.48
CCNE2 O96020 3/20 0.48
CDK4 P11802 3/20 0.48
CCND1 P24385 3/20 0.48
CCNE1 P24864 3/20 0.48
CDK2 P24941 3/20 0.48
SIRT2 Q8IXJ6 2/20 0.43
SIRT1 Q96EB6 1/20 0.43
GSK3B P49841 4/20 0.42
PRKCA P17252 3/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8477326 0.85 GSK3B (0.40) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8477367 0.83 PRKD1 (0.53) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8467101 0.82 PRKD1 (0.53) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8074697 0.80 PRKD1 (0.58) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8464380 0.78 PRKD1 (0.61) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8128283 0.78 PRKCA (0.61) PRKD1TDP1PIM1PRKACAPRKACG
SCHEMBL8466746 0.76 MEN1 (0.48) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8477009 0.76 CCNT1 (0.51) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8467187 0.76 MEN1 (0.45) PRKD1TDP1CCNT1PIM1CDK9
SCHEMBL8464191 0.76 CCNT1 (0.52) PRKD1TDP1CCNT1PIM1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5945440-A Indolocarbazole imides and the use thereof GOEDECKE AKTIENGESELLSCHAFT (DE) 1999-08-31 US disclosed